BR0112765A - l,3-dioxolanos com atividade antitussìgena - Google Patents

l,3-dioxolanos com atividade antitussìgena

Info

Publication number
BR0112765A
BR0112765A BR0112765-9A BR0112765A BR0112765A BR 0112765 A BR0112765 A BR 0112765A BR 0112765 A BR0112765 A BR 0112765A BR 0112765 A BR0112765 A BR 0112765A
Authority
BR
Brazil
Prior art keywords
dioxolanes
antitussive activity
preparation
activity
acetals
Prior art date
Application number
BR0112765-9A
Other languages
English (en)
Inventor
Marcello Allegretti
Maria Candida Cesta
Roberto Curti
Luigi Pellegrini
Gabriella Melillo
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Publication of BR0112765A publication Critical patent/BR0112765A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glass Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"1,3-DIOXOLANOS COM ATIVIDADE ANTITUSSìGENA". A presente invenção refere-se a acetais cíclicos de (S)-3-(4-fenil-1-piperazinil)-1,2-propanodiol úteis como agentes antitussígenos e como intermediários para a preparação de levodropropizina e os sais destes, bem como um processo para a preparação dos referidos acetais.
BR0112765-9A 2000-07-28 2001-07-18 l,3-dioxolanos com atividade antitussìgena BR0112765A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001734A IT1318650B1 (it) 2000-07-28 2000-07-28 1,3-diossolani ad attivita' antitosse.
PCT/EP2001/008304 WO2002010149A1 (en) 2000-07-28 2001-07-18 1,3-dioxolanes with antitussive activity

Publications (1)

Publication Number Publication Date
BR0112765A true BR0112765A (pt) 2004-01-13

Family

ID=11445591

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112765-9A BR0112765A (pt) 2000-07-28 2001-07-18 l,3-dioxolanos com atividade antitussìgena

Country Status (27)

Country Link
US (1) US6835734B2 (pt)
EP (1) EP1307441B1 (pt)
JP (1) JP5107497B2 (pt)
KR (1) KR100781403B1 (pt)
CN (1) CN1204135C (pt)
AT (1) ATE266018T1 (pt)
AU (1) AU2001287638A1 (pt)
BR (1) BR0112765A (pt)
CZ (1) CZ301087B6 (pt)
DE (1) DE60103164T2 (pt)
DK (1) DK1307441T3 (pt)
EE (1) EE05178B1 (pt)
ES (1) ES2219562T3 (pt)
HK (1) HK1058797A1 (pt)
HU (1) HUP0301497A3 (pt)
IL (2) IL153515A0 (pt)
IT (1) IT1318650B1 (pt)
MX (1) MXPA02012920A (pt)
PL (1) PL206307B1 (pt)
PT (1) PT1307441E (pt)
RS (1) RS50861B (pt)
RU (1) RU2276149C2 (pt)
SI (1) SI21040A (pt)
SK (1) SK286794B6 (pt)
TR (1) TR200401315T4 (pt)
UA (1) UA73789C2 (pt)
WO (1) WO2002010149A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318651B1 (it) * 2000-07-28 2003-08-27 Dompe Spa Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
TWI496776B (zh) * 2007-11-15 2015-08-21 Astrazeneca Ab 製備(3aR,4S,6R,6aS)-6-胺基-2,2-二甲基四氫-3aH-環戊并[d][1,3]二氧雜環戊烯-4-醇之純非對映異構性之二苯甲醯-L-酒石酸鹽之方法
EP2070915A1 (en) * 2007-12-03 2009-06-17 A.M.S.A. ANONIMA MATERIE SINTETICHE E AFFINI S.p.A. New process for the synthesis of moguisteine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049660A (en) * 1971-06-18 1977-09-20 Delalande S.A. N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics
IT1203721B (it) * 1983-12-29 1989-02-23 Dompe Farmaceutici Spa Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
NL8801622A (nl) * 1988-06-25 1990-01-16 Stamicarbon Bereiding van enantiomeren van dropropizine.
IT1226570B (it) * 1988-08-01 1991-01-24 Bidachem Spa Procedimento di preparazione della levo- e destro-dropropizina
IT1254452B (it) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IT1254993B (it) * 1992-06-24 1995-10-11 Procedimento per la preparazione degli enantiomeri della dropropizina
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
IT1318651B1 (it) * 2000-07-28 2003-08-27 Dompe Spa Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.

Also Published As

Publication number Publication date
RS50861B (sr) 2010-08-31
IL153515A (en) 2006-12-10
SK286794B6 (sk) 2009-05-07
DE60103164T2 (de) 2005-05-04
MXPA02012920A (es) 2004-04-20
RU2276149C2 (ru) 2006-05-10
CZ2003268A3 (cs) 2003-06-18
CZ301087B6 (cs) 2009-11-04
TR200401315T4 (tr) 2004-07-21
UA73789C2 (en) 2005-09-15
EE05178B1 (et) 2009-06-15
WO2002010149A1 (en) 2002-02-07
US20040038989A1 (en) 2004-02-26
HUP0301497A2 (hu) 2003-09-29
IL153515A0 (en) 2003-07-06
YU3003A (sh) 2006-05-25
EE200300036A (et) 2004-10-15
IT1318650B1 (it) 2003-08-27
AU2001287638A1 (en) 2002-02-13
KR20030016425A (ko) 2003-02-26
KR100781403B1 (ko) 2007-12-03
HK1058797A1 (en) 2004-06-04
PL361172A1 (en) 2004-09-20
SK892003A3 (en) 2003-09-11
DE60103164D1 (de) 2004-06-09
JP5107497B2 (ja) 2012-12-26
DK1307441T3 (da) 2004-08-09
EP1307441B1 (en) 2004-05-06
ITMI20001734A0 (it) 2000-07-28
PT1307441E (pt) 2004-09-30
HUP0301497A3 (en) 2005-08-29
EP1307441A1 (en) 2003-05-07
CN1204135C (zh) 2005-06-01
SI21040A (sl) 2003-04-30
ATE266018T1 (de) 2004-05-15
JP2004505073A (ja) 2004-02-19
ITMI20001734A1 (it) 2002-01-28
PL206307B1 (pl) 2010-07-30
ES2219562T3 (es) 2004-12-01
CN1444578A (zh) 2003-09-24
US6835734B2 (en) 2004-12-28

Similar Documents

Publication Publication Date Title
EA200300503A1 (ru) Новые лекарственные композиции на основе солей тиотропия и солей салметерола
PA8514401A1 (es) Nuevos derivados de piperazina
BR0017030A (pt) Derivados de tiazolilamida
BR0310077A (pt) Novos compostos e sua utilização
BR0110824A (pt) Iminoazinas substituìdas
BR0015254A (pt) Derivados de carbamoiloxialquil-azólio substituìdos em n
BRPI0500590B8 (pt) processo para a síntese de compostos de 1,3,4,5-tetraidro-2h-3-benzazepin-2-ona, e aplicação na síntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável
EA200702004A1 (ru) Соль безилата 7-(2-(4-(3-трифторметилфенил)-1,2,3,6-тетрагидропирид-1-ил)этил)изохинолина, ее получение и применение в терапии
SE9802206D0 (sv) Novel compounds
BR0008682A (pt) 3-amino-3-arilpropan-1-ol, processo para sua produção, seu uso e medicamento
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
BRPI0012475B1 (pt) composto derivado de titánio, seu processo de preparação e utilização, bem como composição para uso oral compreendendo o mesmo.
EA200300706A1 (ru) Замещенные 8-арилхинолины в качестве ингибиторов фосфодиэстеразы-4
BR0112765A (pt) l,3-dioxolanos com atividade antitussìgena
BRPI0416426A (pt) dendrìmeros e seu processo de preparação, compostos, processo para a preparação de compostos e uso dos dendrìmeros
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
BR0016942A (pt) Derivados substituìdos de aminometil-fenil-ciclohexano
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
BR0108990A (pt) Processo para preparação de derivados de pirimidona com atividade antifungos
BR0109784A (pt) Uracilas de fenila substituìdas
BR9805437A (pt) Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos.
BR0106120A (pt) Processo para produção de isolongifolanol
BR9913282A (pt) 3-aril-pirazóis substituìdos
BR0112802A (pt) l,3-dioxolanos 2,2-dissubstituìdos como agentes antitussivos
BR0110959A (pt) Derivados de 7-nitro-2,1,3-benzoxadiazol e 7-nitro-2,1,3-benzotiadiazol, bem como agentes de tingimento para fibras de queratina que contêm esses compostos

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: DOMPE PHA.R.MA S.P.A. (IT)

Free format text: TRANSFERIDO DE: DOMPE S.P.A.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: DOMPE S.P.A. (IT)

Free format text: TRANSFERIDO POR FUSAO DE: DOMPE PHA.R.MA S.P.A.

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.